Approval · Notice of Compliance 19961 · 2017
IMAVEROL: Notice of Compliance 19961
Issued October 25, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19961
- Date
- October 25, 2017
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMAVEROL | 00768685 | Marketed |
Medicinal ingredients
- ENILCONAZOLE 100 MG per ML